Brown, J W L, Cunniffe, N G, Prados, F, Kanber, B, Jones, J L, Needham, E, Georgieva, Z, Rog, D, Pearson, O R, Overell, J, Macmanus, D, Samson, R S, Stutters, J, Ffrench-constant, C, Gandini Wheeler-kingshott, C A M, Moran, C, Flynn, P D, Michell, A W, Franklin, R J M, Chandran, S, Altmann, D R, Chard, D T, Connick, P & Coles, A J 2021, ' Safety and efficacy of bexarotene in patients with relapsing-remitting multiple sclerosis (CCMR One): a randomised, double-blind, placebo-controlled, parallel-group, phase 2a study ', The Lancet Neurology, vol. 20, no. 9, pp. 709-720 . https://doi.org/10.1016/S1474-4422(21)00179-4
Chataway, J, De Angelis, F, Connick, P, Parker, R A, Plantone, D, Doshi, A, John, N, Stutters, J, Macmanus, D, Prados Carrasco, F, Barkhof, F, Ourselin, S, Braisher, M, Ross, M, Cranswick, G, Pavitt, S H, Giovannoni, G, Gandini Wheeler-kingshott, C A, Hawkins, C, Sharrack, B, Bastow, R, Weir, C J & Stallard, N & Chandran, S 2020, ' Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART) : a phase 2b, multiarm, double-blind, randomised placebo-controlled trial ', The Lancet Neurology, vol. 19, no. 3, pp. 214-225 . https://doi.org/10.1016/S1474-4422(19)30485-5 O2, repositorio institucional de la UOC Universitat Oberta de Catalunya (UOC) Chataway, J, De Angelis, F, Connick, P, Parker, R A, Plantone, D, Doshi, A, John, N, Stutters, J, MacManus, D, Prados Carrasco, F, Barkhof, F, Ourselin, S, Braisher, M, Ross, M, Cranswick, G, Pavitt, S H, Giovannoni, G, Gandini Wheeler-Kingshott, C A, Hawkins, C, Sharrack, B, Bastow, R, Weir, C J, Stallard, N, Chandran, S & MS-SMART Investigators 2020, ' Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART) : a phase 2b, multiarm, double-blind, randomised placebo-controlled trial ', The Lancet Neurology, vol. 19, no. 3, pp. 214-225 . https://doi.org/10.1016/S1474-4422(19)30485-5 The Lancet Neurology, 19(3), 214-225. Lancet Publishing Group
Hartung, H-P, Derfuss, T, Cree, B A C, Sormani, M P, Selmaj, K, Stutters, J, Prados, F, MacManus, D, Schneble, H-M, Lambert, E, Porchet, H, Glanzman, R, Warne, D, Curtin, F, Kornmann, G, Buffet, B N, Kremer, D, Küry, P, Leppert, D, Rückle, T & Barkhof, F 2021, ' Efficacy and safety of temelimab in multiple sclerosis: Results of a randomized phase 2b and extension study ', Multiple Sclerosis Journal . https://doi.org/10.1177/13524585211024997 O2, repositorio institucional de la UOC Universitat Oberta de Catalunya (UOC) Multiple Sclerosis Journal. SAGE Publications Ltd
American Journal of Neuroradiology, 41(12), 2209-2218. American Society of Neuroradiology Solanky, B S, John, N A, DeAngelis, F, Stutters, J, Prados, F, Schneider, T, Parker, R A, Weir, C J, Monteverdi, A, Plantone, D, Doshi, A, MacManus, D, Marshall, I, Barkhof, F, Gandini Wheeler-Kingshott, C A M, Chataway, J & MS-SMART Investigators 2020, ' NAA is a marker of disability in secondary-progressive MS : A proton MR spectroscopic imaging study ', American Journal of Neuroradiology, vol. 41, no. 12, pp. 2209-2218 . https://doi.org/10.3174/ajnr.A6809 AJNR Am J Neuroradiol
De Angelis, F, Connick, P, Parker, R A, Plantone, D, Doshi, A, John, N, Stutters, J, Macmanus, D, Prados, F, Marshall, I, Solanky, B, Samson, R S, Barkhof, F, Ourselin, S, Braisher, M, Ross, M, Cranswick, G, Pavitt, S H, Gnanapavan, S, Giovannoni, G, Wheeler-kingshott, C A G, Hawkins, C, Sharrack, B, Bastow, R, Weir, C J, Stallard, N, Chandran, S & Chataway, J 2020, ' Amiloride, fluoxetine or riluzole to reduce brain volume loss in secondary progressive multiple sclerosis: the MS-SMART four-arm RCT ', Efficacy and Mechanism Evaluation, vol. 7, no. 3, pp. 1-72 . https://doi.org/10.3310/eme07030 Efficacy and Mechanism Evaluation, Vol 7, Iss 3 (2020)